Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
4 More presentations in this session
Mrs V. Samsone (Vilnius, LT)
Doctor A. Gutowska (Gdansk, PL)
Doctor R. Fernandes (Coimbra, PT)
Doctor T. Pereira dos Santos (Coimbra, PT)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
